JERUSALEM & TARRYTOWN, N.Y.-- --Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. today provided an update on fasinumab, triggered by a recent development in a Phase 2b fasinumab study in patients with chronic low back pain. Fasinumab is an investigational Nerve Growth Factor antibody in clinical development for osteoarthritis pain and chronic low back pain.
http://ift.tt/2dvSRFI
Tarrytown News: Local news for Tarrytown, NY continually updated from thousands of sources monitored by the B Media Net.
Subscribe to:
Post Comments (Atom)
Popular Tarrytown Roundup Posts
-
... Bronx, forced service on the Hudson Line and Amtrak's Empire Line to be suspended. With no trains running between Tarrytown and Gran...
-
1) Tonight is your chance to weigh in on a very crucial topic for our Tarrytown and Sleepy Hollow public schools. UFSD Tarrytowns Board of E...
-
As the enrollment period for health insurance coverage in 2015 begins, The Business Council of Westchester invited a panel of health care ex...
-
... firefighter, fire investigator and emergency medical technician from 1977-2001: As a former fire chief in North Tarrytown, N.Y., Kosilla...
-
... to take place in the campus presentation room. Many Westchester school districts, including most recently in Tarrytown, have opted to us...
-
Feb. 28, 2014 - TARRYTOWN, N.Y. -- Hilton Worldwide has honored Celeste Reeves, Sales Office Manager at the DoubleTree by Hilton Tarrytown, ...
-
In honor of 25 years, Food Bank for Westchester saluted its board presidents at the annual Valentine's Day Wine Tasting Dinner on Friday...
-
Tarrytown Honda announces that Dwight Dachnowicz, owner of Tarrytown Honda, has finished his three-year term as Northeast Dealer Advisory Bo...
-
Born in North Tarrytown on March 15, 1989, he was the son of Brian and Geralyn Balthazard. Brian graduated from Transfiguration School and S...
-
Tarrytown resident Vic Weinstein, 75, a member of the Town of Greenburgh Planning Board, died on Thursday, Dec. 5. Weinstein was a member of...
No comments:
Post a Comment